{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T22:12:23Z","timestamp":1648505543370},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2003,3,6]],"date-time":"2003-03-06T00:00:00Z","timestamp":1046908800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2003,4]]},"DOI":"10.1007\/s00108-003-0875-y","type":"journal-article","created":{"date-parts":[[2016,10,17]],"date-time":"2016-10-17T17:58:54Z","timestamp":1476727134000},"page":"433-439","source":"Crossref","is-referenced-by-count":1,"title":["Autoimmunthyreoiditis"],"prefix":"10.1007","volume":"44","author":[{"given":"K.-H.","family":"Usadel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.-M.","family":"Schumm-Draeger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2003,3,6]]},"reference":[{"key":"0875_CR1","doi-asserted-by":"crossref","unstructured":"Allan WC, Haddow JE, Palomaki GE et al. (2000) Maternal thyroid deficiency and pregnancy complications: implications for population screening. J Med Screen 7: 127\u2013130","DOI":"10.1136\/jms.7.3.127"},{"key":"0875_CR2","doi-asserted-by":"crossref","unstructured":"Canaris GI, Manowitz NR, Mavor GM et al. (2000) The Colorado thyroid disease prevalence study. Arch Intern Med 160: 526\u2013534","DOI":"10.1001\/archinte.160.4.526"},{"key":"0875_CR3","doi-asserted-by":"crossref","unstructured":"Cencanni M, Cesareo R, Verallo O et al. (1997) Reversible increase of intraocular pressure in subclinical hypothyroid patients. Eur J Endocrinol 136: 595\u2013598","DOI":"10.1530\/eje.0.1360595"},{"key":"0875_CR4","doi-asserted-by":"crossref","unstructured":"Cooper DS, Halpern R, Wood LC et al. (1984) L-thyroxine therapy in subclinical hypothyroidism: a double-blind, placebo-controlled trial. Ann Intern Med 101: 18\u201324","DOI":"10.7326\/0003-4819-101-1-18"},{"key":"0875_CR5","doi-asserted-by":"crossref","unstructured":"Cooper DS (2001) Subclinical hypothyroidism. N Engl J Med 345: 260\u2013265","DOI":"10.1056\/NEJM200107263450406"},{"key":"0875_CR6","doi-asserted-by":"crossref","unstructured":"Danese MD, Powe NR, Sawin CT et al. (1996) Screening for mild thyroid failure at the periodic health examination; a decision and cost effectiveness analysis. JAMA 276: 285\u2013292","DOI":"10.1001\/jama.1996.03540040029029"},{"key":"0875_CR7","doi-asserted-by":"crossref","unstructured":"Danese MD, Ladenson PW, Meinert CL et al. (2000) Effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature. J Clin Endocrinol Metab 85: 2993\u20133001","DOI":"10.1210\/jc.85.9.2993"},{"key":"0875_CR8","doi-asserted-by":"crossref","unstructured":"Dickman T, Lansberg PJ, Kastelein JJ et al. (1995) Prevalence and correction of hypothyroidism in a large cohort of patients referred for dyslipidemia. Arch Intern Med 155: 1490\u20131495","DOI":"10.1001\/archinte.1995.00430140052004"},{"key":"0875_CR9","doi-asserted-by":"crossref","unstructured":"Haddow JE, Palomaki GE, Allan WC et al. (1999) Maternal thyroid deficiency during pregnancy and subsequent neurophsycological development of the child. N Engl J Med 341: 549\u2013555","DOI":"10.1056\/NEJM199908193410801"},{"key":"0875_CR10","doi-asserted-by":"crossref","unstructured":"Hak AE, Pols AP, Visser TJ et al. (2000) Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam study. Ann Intern Med 132: 270\u2013278","DOI":"10.7326\/0003-4819-132-4-200002150-00004"},{"key":"0875_CR11","doi-asserted-by":"crossref","unstructured":"Helfand M, Redfern CC (1999) Screening for thyroid disease: an update. Ann Intern Med 130: 246\u2013251","DOI":"10.7326\/0003-4819-130-2-199901190-00018"},{"key":"0875_CR12","doi-asserted-by":"crossref","unstructured":"Jaeschke R, Guyatt G, Gerstein H et al. (1996) Does treatment with L-thyroxine influence health status in middle-aged and older adults with subclinical hypothyroidism? J Gen Intern Med 11: 744\u2013749","DOI":"10.1007\/BF02598988"},{"key":"0875_CR13","unstructured":"Kong WM, Sheikh M, Lumb P et al. (2000) A randomized controlled trial of thyroxine treatment in mild subclinical hypothyroidism. Endocrine Society Press, Abstract 597"},{"key":"0875_CR14","doi-asserted-by":"crossref","unstructured":"Kumana CR, Cheung BMY, Lauder IJ et al. (1999) Gauging the impact of statins using number needed to treat. JAMA 282: 1899\u20131901","DOI":"10.1001\/jama.282.20.1899"},{"key":"0875_CR15","unstructured":"Lincoln SR, Ke RW, Kutch WH et al. (1999) Screening for hypothyroidism in infertile women. J Reprod Med 44: 455\u2013457"},{"key":"0875_CR16","unstructured":"Meier C, Roth CB, Huber G et al. (2000) Clinical and metabolic effects of thyroxine replacement in patients with mild thyroid failure: results from a double-blind placebo-controlled study. Endocrine Society Press. Abtract 573"},{"key":"0875_CR17","unstructured":"Monzani F, Del Guerra P, Caraccio N et al. (1993) Subclinical hypothyroidism: neurobehavioral features and beneficial effect of L-thyroxine treatment. Clin Invest 71: 367\u2013371"},{"key":"0875_CR18","doi-asserted-by":"crossref","unstructured":"Nystr\u00f6m E, Caidahi K, Fager G et al. (1988) A double-blind, cross-over 12 month study of L-thyroxine treatment of women with \"subclinical\" hypothyroidism. Clin Endocrinol 29: 63\u201375","DOI":"10.1111\/j.1365-2265.1988.tb00250.x"},{"key":"0875_CR19","doi-asserted-by":"crossref","unstructured":"Padberg S, Heller K, Usadel KH, Schumm-Draeger PM (2001) One year prophylactic treatment of Hashimoto's thyroiditis patients with levothyroxine: is there a benefit? Thyroid 11: 49\u2013255","DOI":"10.1089\/105072501750159651"},{"key":"0875_CR20","doi-asserted-by":"crossref","unstructured":"Staub JJ, Althaus BU, Engler H et al. (1992) Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues. Am J Med 92: 631\u2013642","DOI":"10.1016\/0002-9343(92)90782-7"},{"key":"0875_CR21","doi-asserted-by":"crossref","unstructured":"Tunbridge WMG, Evered DC, Hall R et al. (1977) The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol 7: 481\u2013493","DOI":"10.1111\/j.1365-2265.1977.tb01340.x"},{"key":"0875_CR22","doi-asserted-by":"crossref","unstructured":"Vanderpump MP, Tunbridge WM, French JM et al. (1995) The incidence of thyroid disorders in the community: a twenty year follow-up of the Whickham survey. Clin Endocrinol 43: 55\u201368","DOI":"10.1111\/j.1365-2265.1995.tb01894.x"},{"key":"0875_CR23","unstructured":"Vunderpump MP, Tunbridge WMG, French JM et al. (1996) The development of ischemic heart disease relation to autoimmune thyroid disease in a 20\u00a0year follow-up study of an English community. Thyroid 6: 155\u2013160"},{"key":"0875_CR24","doi-asserted-by":"crossref","unstructured":"Weetman AP (1997) Hypothyroidism: screening and subclinical disease. BMJ 314","DOI":"10.1136\/bmj.314.7088.1175"},{"key":"0875_CR25","doi-asserted-by":"crossref","unstructured":"Zulewski H, M\u00fcller R, Exer P et al. (1997) Estimation of tissue hypothyroidism by a new clinical score: evaluation of patients with various grades of hypothyroidism and controls. J Clin Endocrinol Metab 82: 771\u2013776","DOI":"10.1210\/jc.82.3.771"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-003-0875-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-003-0875-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-003-0875-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-003-0875-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T14:10:40Z","timestamp":1568470240000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-003-0875-y"}},"subtitle":["Behandlung mit Schilddr\u00fcsenhormonen bei subklinischer Hypothyreose oder schon bei Euthyreose?"],"short-title":[],"issued":{"date-parts":[[2003,3,6]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,4]]}},"alternative-id":["0875"],"URL":"https:\/\/doi.org\/10.1007\/s00108-003-0875-y","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,3,6]]}}}